Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Jeroen Veltman"'
Autor:
Wouter Wolfkamp, Joyce Meijer, Jolanda C. vanHoeve, Felice vanErning, Lioe‐Fee deGeus‐Oei, Ignace deHingh, Jeroen Veltman, Sabine Siesling, the COVID and Cancer‐NL Consortium
Publikováno v:
Cancer Medicine, Vol 13, Iss 1, Pp n/a-n/a (2024)
Abstract Background In the Netherlands, the COVID‐19 pandemic resulted in a temporary halt of population screening for cancer and limited hospital capacity for non‐COVID care. We aimed to investigate the impact of the pandemic on the in‐hospita
Externí odkaz:
https://doaj.org/article/77710eafa4424646b9d2936bf7cf3c3e
Autor:
Tianyu Zhang, Tao Tan, Luyi Han, Linda Appelman, Jeroen Veltman, Ronni Wessels, Katya M. Duvivier, Claudette Loo, Yuan Gao, Xin Wang, Hugo M. Horlings, Regina G. H. Beets-Tan, Ritse M. Mann
Publikováno v:
npj Breast Cancer, Vol 9, Iss 1, Pp 1-12 (2023)
Abstract Accurately determining the molecular subtypes of breast cancer is important for the prognosis of breast cancer patients and can guide treatment selection. In this study, we develop a deep learning-based model for predicting the molecular sub
Externí odkaz:
https://doaj.org/article/fe8d7f10afa0492b927494114288cff3
Autor:
Madelon M. Voets, Catharina G. M. Groothuis-Oudshoorn, Liset H. J. Veneklaas, Srirang Manohar, Mariël Brinkhuis, Jeroen Veltman, Linda de Munck, Lioe-Fee de Geus-Oei, Mireille J. M. Broeders, Sabine Siesling
Publikováno v:
Current Oncology, Vol 28, Iss 6, Pp 4998-5008 (2021)
The goal of this study was to describe the variation in hospital-based diagnostic care activities for patients with symptomatology suspect for breast cancer in The Netherlands. Two cohorts were included: the ‘benign’ cohort (30,334 women suspecte
Externí odkaz:
https://doaj.org/article/23e1b7ef0be545eda8595c6c94730ea4
Autor:
Marissa C. van Maaren, Agustín Ortega Ávila, Jeannette G. van Manen, Marian BE. Menke-Pluijmers, Jeroen Veltman, Joost Bart, Pieter J. Westenend, Sabine Siesling
Publikováno v:
Breast, Vol 59, Iss , Pp 376-382 (2021)
Purpose: We analysed incidence, treatment, survival, occurrence of ductal carcinoma in situ (DCIS) and invasive breast cancer (IBC) after lobular carcinoma in situ (LCIS) in the Netherlands. Methods: All women diagnosed with classic LCIS between 1989
Externí odkaz:
https://doaj.org/article/525cbb0680f24c4cb205fada0329fb19
Publikováno v:
Cancer Research. 83:P1-05
Objective: The COVID-19 pandemic has had an impact on health care. In the Netherlands, hospital capacity for non-covid care was limited and population screening temporarily halted. The aim of this study was to investigate the impact of the pandemic o
Autor:
Andrea Cozzi, Giovanni Di Leo, Nehmat Houssami, Fiona J. Gilbert, Thomas H. Helbich, Marina Álvarez Benito, Corinne Balleyguier, Massimo Bazzocchi, Peter Bult, Massimo Calabrese, Julia Camps Herrero, Francesco Cartia, Enrico Cassano, Paola Clauser, Marcos F. de Lima Docema, Catherine Depretto, Valeria Dominelli, Gábor Forrai, Rossano Girometti, Steven E. Harms, Sarah Hilborne, Raffaele Ienzi, Marc B. I. Lobbes, Claudio Losio, Ritse M. Mann, Stefania Montemezzi, Inge-Marie Obdeijn, Umit A. Ozcan, Federica Pediconi, Katja Pinker, Heike Preibsch, José L. Raya Povedano, Carolina Rossi Saccarelli, Daniela Sacchetto, Gianfranco P. Scaperrotta, Margrethe Schlooz, Botond K. Szabó, Donna B. Taylor, Özden S. Ulus, Mireille Van Goethem, Jeroen Veltman, Stefanie Weigel, Evelyn Wenkel, Chiara Zuiani, Francesco Sardanelli
Publikováno v:
European Radiology. Springer-Verlag
European radiology
European Radiology
European radiology
European Radiology
Objectives To report mastectomy and reoperation rates in women who had breast MRI for screening (S-MRI subgroup) or diagnostic (D-MRI subgroup) purposes, using multivariable analysis for investigating the role of MRI referral/nonreferral and other co
Publikováno v:
Value in health, 25(3), 340-349. Elsevier
Objectives: This study aimed to systematically review recent health economic evaluations (HEEs) of artificial intelligence (AI) applications in healthcare. The aim was to discuss pertinent methods, reporting quality and challenges for future implemen
Autor:
Jeroen Veltman, Sabine Siesling, Pieter J. Westenend, Agustin Ortega Avila, Marian B. E. Menke-Pluijmers, Jeannette G. van Manen, Marissa C. van Maaren, Joost Bart
Publikováno v:
Breast, Vol 59, Iss, Pp 376-382 (2021)
The Breast : Official Journal of the European Society of Mastology
The Breast, 59, 376-382. Churchill Livingstone
Breast, 59, 376-382. Churchill Livingstone
The Breast : Official Journal of the European Society of Mastology
The Breast, 59, 376-382. Churchill Livingstone
Breast, 59, 376-382. Churchill Livingstone
Purpose We analysed incidence, treatment, survival, occurrence of ductal carcinoma in situ (DCIS) and invasive breast cancer (IBC) after lobular carcinoma in situ (LCIS) in the Netherlands. Methods All women diagnosed with classic LCIS between 1989 a
Autor:
Lisbeth J. Boersma, Miha Lavric, Vinzenz Voelkel, Teresa Draeger, Sabine Siesling, Hendrik Koffijberg, Anneriet Dassen, Annemieke Witteveen, Jeroen Veltman, Gabe S. Sonke, Catharina G.M. Groothuis-Oudshoorn
Publikováno v:
Cancer Research. 80:P5-08
Purpose: An important aim of follow-up after primary breast cancer treatment is early detection of locoregional recurrences (LRR) to improve survival. This study proposes and simulates two personalized follow-up schemes based on LRR risk predictions
Autor:
O. Sjoerd Klaver, Hans de Jong, Christina A. Hulsbergen-van de Kaa, Jeroen Veltman, Wim Van Criekinge, Inge M. van Oort, Marloes van der Leest, Rianne J. Hendriks, Gerjon Hannink, J.P. Michiel Sedelaar, Jelle O. Barentsz, Peter F.A. Mulders, Jack A. Schalken, Anglita YantiSetiasti, Bas Israël, Erik B. Cornel, E. David Crawford
Publikováno v:
PROSTATE CANCER AND PROSTATIC DISEASES
Prostate Cancer and Prostatic Diseases, 24, 1110-1119
Prostate Cancer and Prostatic Diseases
Prostate Cancer and Prostatic Diseases, 24, 4, pp. 1110-1119
Prostate Cancer and Prostatic Diseases, 24, 1110-1119
Prostate Cancer and Prostatic Diseases
Prostate Cancer and Prostatic Diseases, 24, 4, pp. 1110-1119
Background Risk stratification in men with suspicion of prostate cancer (PCa) requires reliable diagnostic tests, not only to identify high-grade PCa, also to minimize the overdetection of low-grade PCa, and reduction of “unnecessary” prostate MR